Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Collagenase Santyl. Always confirm against the full prescribing information.
47 interactions
Acenocoumarol
The risk or severity of adverse effects can be increased when Acenocoumarol is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Alteplase
The risk or severity of adverse effects can be increased when Alteplase is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Antithrombin Alfa
The risk or severity of adverse effects can be increased when Antithrombin Alfa is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Antithrombin III human
The risk or severity of adverse effects can be increased when Antithrombin III human is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Apixaban
The risk or severity of adverse effects can be increased when Apixaban is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Argatroban
The risk or severity of adverse effects can be increased when Argatroban is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Astaxanthin
The risk or severity of adverse effects can be increased when Astaxanthin is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Betrixaban
The risk or severity of adverse effects can be increased when Betrixaban is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Bivalirudin
The risk or severity of adverse effects can be increased when Bivalirudin is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Brinase
The risk or severity of adverse effects can be increased when Brinase is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Cangrelor
The risk or severity of adverse effects can be increased when Cangrelor is combined with Collagenase clostridium histolyticum.
Level 1 evidence
Dabigatran etexilate
The risk or severity of adverse effects can be increased when Dabigatran etexilate is combined with Collagenase clostridium histolyticum.
Collagenase Santyl has 47 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Collagenase Santyl has 0 major, 38 moderate, and 9 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Collagenase Santyl. Always confirm against the full prescribing information.